<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rentrad</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник рентгенологии и радиологии</journal-title><trans-title-group xml:lang="en"><trans-title>Journal of radiology and nuclear medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0042-4676</issn><issn pub-type="epub">2619-0478</issn><publisher><publisher-name>Limited Liability Company "LUCHEVAYA DIAGNOSTIKA", Russian Association of Radiologists</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20862/0042-4676-2026-107-1-26-36</article-id><article-id custom-type="elpub" pub-id-type="custom">rentrad-1027</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Мультимодальный подход в диагностике артериита Кавасаки</article-title><trans-title-group xml:lang="en"><trans-title>A Multimodal Approach in the Diagnosis of Kawasaki Disease</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3261-9986</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малов</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Malov</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малов Алексей Анатольевич - ассистент кафедры онкологии с курсом лучевой диагностики и лучевой терапии ФГБОУ ВО «Казанский ГМУ» Минздрава России, врач-рентгенолог отделения лучевой диагностики № 2 ГАУЗ «ДРКБ Министерства здравоохранения Республики Татарстан», преподаватель кафедры радиологии, радиотерапии, радиационной гигиены и радиационной безопасности им. академиков А.С. Павлова и Ф.Г. Кроткова ФГБОУ ДПО «РМА НПО» Минздрава России.</p><p>Ул. Бутлерова, 49, Казань, 420012; Оренбургский тракт, 140, Казань, 420138; ул. Баррикадная, 2/1, стр. 1, Москва, 125993</p></bio><bio xml:lang="en"><p>Aleksei A. Malov - Assistant Professor, Chair of Oncology with a Course in Radiation Diagnostics and Radiation Therapy, Kazan SMU; Radiologist, Department of Radiology Diagnostics No. 2, Children’s RCH; Lecturer, Chair of Radiology, Radiotherapy, Radiation Hygiene and Radiation Safety, RMA of Continuing Professional Education.</p><p>Ul. Butlerova, 49, Kazan, 420012; Orenburgsky trakt, 140, Kazan, 420011; ul. Barrikadnaya, 2/1, str. 1, Moscow, 123001</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-8714-3531</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курбангалеева</surname><given-names>К. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurbangaleeva</surname><given-names>K. Sh.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Курбангалеева Камиля Шавкатовна, ординатор кафедры онкологии с курсом лучевой диагностики и лучевой терапии.</p><p>Ул. Бутлерова, 49, Казань, 420012</p></bio><bio xml:lang="en"><p>Kamilya Sh. Kurbangaleeva - Resident, Chair of Oncology with a Course in Radiation Diagnostics and Radiation Therapy.</p><p>Ul. Butlerova, 49, Kazan, 420012</p></bio><email xlink:type="simple">kamilya.khayrtdinova@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России; ГАУЗ «Детская республиканская клиническая больница Министерства здравоохранения Республики Татарстан»; ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University; Children’s Republican Clinical Hospital; Russian Medical Academy of Continuing Professional Education</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБОУ ВО «Казанский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>19</day><month>05</month><year>2026</year></pub-date><volume>107</volume><issue>1</issue><fpage>26</fpage><lpage>36</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малов А.А., Курбангалеева К.Ш., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Малов А.А., Курбангалеева К.Ш.</copyright-holder><copyright-holder xml:lang="en">Malov A.A., Kurbangaleeva K.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.russianradiology.ru/jour/article/view/1027">https://www.russianradiology.ru/jour/article/view/1027</self-uri><abstract><sec><title>Актуальность</title><p>Актуальность. Синдром Кавасаки – системный васкулит, поражающий преимущественно детей до 5 лет. Особую опасность представляют коронарные аневризмы, развивающиеся у 15–25% нелеченых пациентов и способные приводить к инфаркту миокарда и внезапной сердечной смерти. Внедрение внутривенного иммуноглобулина снизило частоту этого осложнения до 3–5%, однако у 10% больных наблюдается резистентность к терапии. Рост атипичных форм и появление мультисистемного воспалительного синдрома у детей, ассоциированного с COVID-19, повышают значимость точной и своевременной диагностики. Цель: определение роли и места, изучение информативности методов визуализации в диагностике синдрома Кавасаки и его осложнений у детей.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Проведен ретроспективный анализ данных 16 пациентов с диагнозом синдрома Кавасаки (средний возраст 3,5±1,8 года) за 3-летний период с 1 января 2022 г. Эхокардиографию (ЭхоКГ) проводили на ультразвуковом сканере Philips EPIQ 7 с применением датчиков S5-1 (1–5 МГц) и S8-3 (3–8 МГц), оценивали диаметр коронарных артерий и характеристики кровотока. Выполняли компьютерную томографическую ангиографию (КТА) на 640-срезовом томографе Canon Aquilion ONE с болюсным введением контрастного вещества и синхронизацией с электрокардиографией. При подозрении на сопутствующий миокардит отдельным пациентам проводили магнитно-резонансную томографию (МРТ) сердца на аппарате Siemens Aera 1,5 Тл, включавшую получение T1и T2-взвешенных изображений, а также оценку позднего контрастного усиления миокарда после внутривенного контрастирования.</p></sec><sec><title>Результаты</title><p>Результаты. ЭхоКГ выполнена всем 16 пациентам, КТА – 7, МРТ сердца – 5. Доля пациентов с развитием коронарных аневризм составила 75% (12 из 16). Наиболее часто наблюдалось сочетанное поражение нескольких артерий (58,3%). Динамическое наблюдение через 6–12 мес выявило в целом благоприятный прогноз: 27,3% средних и 70% малых аневризм остались без динамики или регрессировали. Однако в 10% случаев малых коронарных аневризм отмечено прогрессирование, что подчеркивает необходимость тщательного длительного мониторинга даже за небольшими изменениями. Частота острых кардиальных осложнений (острый коронарный синдром – 18,8%) в нашей когорте указывает на сохраняющийся риск ишемических событий. Различия в размерах аневризм, измеренных с помощью КТА и ЭхоКГ, были статистически незначимы (парный t-критерий Стьюдента: t(13)=1,09; p=0,297). В то же время КТА выявила критически важные для прогноза и тактики детали, пропущенные на ЭхоКГ: аномалию отхождения правой коронарной артерии, пристеночный тромбоз и кальцинат, а также (в 1 случае) истинную протяженность поражения. У 1 пациента по данным МРТ был верифицирован миокардит: проявления дилатации левого желудочка и снижение сократительной функции, а также признаки отека по T2 tirm и отсроченное накопление парамагнитного контрастного вещества характерного некоронарного паттерна.</p></sec><sec><title>Заключение</title><p>Заключение. ЭхоКГ остается методом выбора в остром периоде в силу раннего возраста детей. КТА наиболее информативна для оценки дистальных отделов коронарных артерий и выявления осложнений (тромбозов, кальциноза, стеноза), МРТ сердца – для диагностики сочетанного воспалительного процесса. Оптимальная диагностическая стратегия направлена на выявление и динамическое наблюдение изменений и должна основываться на рациональном сочетании этих методов с учетом фазы заболевания и возраста.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Background</title><p>Background. Kawasaki syndrome is a systemic vasculitis that mainly affects children under 5 years of age. Coronary aneurysms, which develop in 15–25% of untreated patients and can lead to myocardial infarction and sudden cardiac death, are particularly dangerous. The introduction of intravenous immunoglobulin reduced the incidence of this complication to 3–5%, however, 10% of patients show resistance to therapy. The growth of atypical forms and the appearance of multisystem inflammatory syndrome in children associated with COVID-19 increase the importance of accurate and timely diagnosis.</p></sec><sec><title>Objective</title><p>Objective: determining the role and place, studying the informative value of imaging methods in the diagnosis of Kawasaki syndrome and its complications in children.</p></sec><sec><title>Material and methods</title><p>Material and methods. For the period of 3 years from January 1, 2022, a retrospective analysis of the data of 16 patients with Kawasaki syndrome (mean age 3.5±1.8 years) was conducted. Echocardiography (EchoCG) was performed on a Philips EPIQ 7 ultrasound scanner using S5-1 (1–5 MHz) and S8-3 (3–8 MHz) sensors. The diameter of the coronary arteries and blood flow characteristics were evaluated. Computed tomography angiography (CTА) was carried out on a Canon Aquilion ONE 640-slice tomograph with bolus contrast agent injection and synchronization with electrocardiography. For suspected concomitant myocarditis, individual patients underwent heart magnetic resonance imaging (MRI) using a Siemens Aera 1.5 T device, which included obtaining T1and T2-weighted images, as well as assessing late contrast enhancement in myocardium after intravenous injection.</p></sec><sec><title>Results</title><p>Results. EchoCG was performed in all 16 patients, CTА in 7, and heart MRI in 5. The proportion of patients with coronary aneurysms was 75% (12 out of 16). Combined lesion of several arteries was most often observed (58.3%). Dynamic follow-up after 6–12 months revealed a generally favorable prognosis: 27.3% of medium and 70% of small aneurysms remained without dynamics or regressed. However, 10% of small coronary aneurysms progressed, which underscored the need for careful, long-term monitoring of even small changes. The incidence of acute cardiac complications (acute coronary syndrome – 18.8%) in our cohort indicates a continuing risk of ischemic events. The differences in aneurysm sizes measured by CTА and EchoCG were not statistically significant (paired Student’s t-test: t(13)=1.09; p=0.297). At the same time, CTА revealed details critical for prognosis and tactics that were missed by EchoCG: an anomaly of the right coronary artery, mural thrombosis and calcification, as well as (in 1 case) the true extent of the lesion. Myocarditis was verified in 1 patient according to MRI data, namely, manifestations of left ventricular dilation and decreased contractile function, as well as edema signs by T2-tirm and late gadolinium enhancement, delayed accumulation of paramagnetic contrast agent of a characteristic non-coronary pattern.</p></sec><sec><title>Conclusion</title><p>Conclusion. EchoCG remains the method of choice in the acute period due to the early age of children. CTА is the most informative for assessing the distal sections of the coronary arteries and detecting complications (thrombosis, calcification, stenosis), while heart MRI is used to diagnose a combined inflammatory process. The optimal diagnostic strategy is aimed at detecting and dynamically monitoring the identified changes and should be based on a rational combination of these methods, taking into account the phase of the disease and age.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром Кавасаки</kwd><kwd>коронарные аневризмы</kwd><kwd>эхокардиография</kwd><kwd>комьютерная томографическая ангиография</kwd><kwd>магнитно-резонансная томография сердца</kwd><kwd>миокардит</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Kawasaki syndrome</kwd><kwd>coronary aneurysms</kwd><kwd>echocardiography</kwd><kwd>computed tomography angiography</kwd><kwd>heart magnetic resonance imaging</kwd><kwd>myocarditis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gkoutzourelas A, Bogdanos DP, Sakkas LI. Kawasaki disease and COVID-19. Mediterr J Rheumatol. 2020; 31(Suppl 2): 268–74. https://doi.org/10.31138/mjr.31.3.268.</mixed-citation><mixed-citation xml:lang="en">Gkoutzourelas A, Bogdanos DP, Sakkas LI. Kawasaki disease and COVID-19. Mediterr J Rheumatol. 2020; 31(Suppl 2): 268–74. https://doi.org/10.31138/mjr.31.3.268.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rigante D. Kawasaki disease as the immune-mediated echo of a viral infection. Mediterr J Hematol Infect Dis. 2020; 12(1): e2020039. https://doi.org/10.4084/MJHID.2020.039.</mixed-citation><mixed-citation xml:lang="en">Rigante D. Kawasaki disease as the immune-mediated echo of a viral infection. Mediterr J Hematol Infect Dis. 2020; 12(1): e2020039. https://doi.org/10.4084/MJHID.2020.039.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Medaglia AA, Siracusa L, Gioè C, et al. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital J Pediatr. 2021; 47(1): 95. https://doi.org/10.1186/s13052-021-01041-4.</mixed-citation><mixed-citation xml:lang="en">Medaglia AA, Siracusa L, Gioè C, et al. Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature. Ital J Pediatr. 2021; 47(1): 95. https://doi.org/10.1186/s13052-021-01041-4.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Гедике Г., Хотама П., Хайнкинг Б. Болезнь Кавасаки – новые данные. Вопросы современной педиатрии. 2010; 9(1): 104–15.</mixed-citation><mixed-citation xml:lang="en">Gaedicke G, Hotama P, Heineking B. Kawasaki disease – an update. Current Pediatrics. 2010; 9(1): 104–15 (in Russ).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Брегель Л.В., Субботин В.М., Белозеров Ю.М. Этиология болезни Кавасаки. Клиническая микробиология и антимикробная химиотерапия. 2002; 4(3): 239–47.</mixed-citation><mixed-citation xml:lang="en">Bregel LV, Subbotin VM, Belozerov YuM. Aetiology of Kawasaki disease. Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(3): 239–47 (in Russ).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Самедова А.Г., Трифонова Л.В., Голованова Н.Ю. Болезнь Кавасаки: эпидемиология, клиническая картина и оценка качества жизни детей. Доктор.Ру. 2025; 24(7): 81–6. https://doi.org/10.31550/1727-2378-2025-24-7-81-86.</mixed-citation><mixed-citation xml:lang="en">Samedova AG, Trifonova LV, Golovanova NYu. Kawasaki disease: epidemiology, clinical presentation and quality of life assessment in children. Doctor.Ru. 2025; 24(7): 81–6 (in Russ). https://doi.org/10.31550/1727-2378-2025-24-7-81-86.]</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tai IH, Hsieh KS, Kuo HC. Beaded coronary aneurysm in Kawasaki disease. Children. 2022; 9(10): 1463. https://doi.org/10.3390/children9101463.</mixed-citation><mixed-citation xml:lang="en">Tai IH, Hsieh KS, Kuo HC. Beaded coronary aneurysm in Kawasaki disease. Children. 2022; 9(10): 1463. https://doi.org/10.3390/children9101463.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol. 2016; 67(14): 1738–49. https://doi.org/10.1016/j.jacc.2015.12.073.</mixed-citation><mixed-citation xml:lang="en">Newburger JW, Takahashi M, Burns JC. Kawasaki disease. J Am Coll Cardiol. 2016; 67(14): 1738–49. https://doi.org/10.1016/j.jacc.2015.12.073.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang D, Liu L, Huang X, Tian J. Insights into coronary artery lesions in Kawasaki disease. Front Pediatr. 2020; 8: 493. https://doi.org/10.3389/fped.2020.00493.</mixed-citation><mixed-citation xml:lang="en">Zhang D, Liu L, Huang X, Tian J. Insights into coronary artery lesions in Kawasaki disease. Front Pediatr. 2020; 8: 493. https://doi.org/10.3389/fped.2020.00493.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon JB, Daniels LB, Kahn AM, et al. The Spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease. JACC Cardiovasc Interv. 2016; 9(7): 687–96. https://doi.org/10.1016/j.jcin.2015.12.011.</mixed-citation><mixed-citation xml:lang="en">Gordon JB, Daniels LB, Kahn AM, et al. The Spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease. JACC Cardiovasc Interv. 2016; 9(7): 687–96. https://doi.org/10.1016/j.jcin.2015.12.011.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Barman P, Pilania RK, Cv G, et al. Treatment intensification in Kawasaki disease – current perspectives. Expert Rev Clin Immunol. 2024; 20(10): 1179–91. https://doi.org/10.1080/1744666X.2024.2378900.</mixed-citation><mixed-citation xml:lang="en">Barman P, Pilania RK, Cv G, et al. Treatment intensification in Kawasaki disease – current perspectives. Expert Rev Clin Immunol. 2024; 20(10): 1179–91. https://doi.org/10.1080/1744666X.2024.2378900.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Кирилина С.А. Синдром Кавасаки у детей – актуальное. Практика педиатра. 2021; 4: 5–11.</mixed-citation><mixed-citation xml:lang="en">Kirilina SA. Kawasaki syndrom in children – current. Pediatrician's Practice. 2021; 4: 5–11 (in Russ).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Friedman KG, Gauvreau K, Hamaoka-Okamoto A, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc. 2016; 5(9): e003289. https://doi.org/10.1161/JAHA.116.003289.</mixed-citation><mixed-citation xml:lang="en">Friedman KG, Gauvreau K, Hamaoka-Okamoto A, et al. Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc. 2016; 5(9): e003289. https://doi.org/10.1161/JAHA.116.003289.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lee SM, Lee JB, Go YB, et al. Prediction of resistance to standard intravenous immunoglobulin therapy in kawasaki disease. Korean Circ J. 2014; 44(6): 415–22. https://doi.org/10.4070/kcj.2014.44.6.415.</mixed-citation><mixed-citation xml:lang="en">Lee SM, Lee JB, Go YB, et al. Prediction of resistance to standard intravenous immunoglobulin therapy in kawasaki disease. Korean Circ J. 2014; 44(6): 415–22. https://doi.org/10.4070/kcj.2014.44.6.415.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ferrara G, Giani T, Caparello MC, et al. Anakinra for treatmentresistant Kawasaki disease: evidence from a literature review. Paediatr Drugs. 2020; 22(6): 645–52. https://doi.org/10.1007/s40272-020-00421-3.</mixed-citation><mixed-citation xml:lang="en">Ferrara G, Giani T, Caparello MC, et al. Anakinra for treatmentresistant Kawasaki disease: evidence from a literature review. Paediatr Drugs. 2020; 22(6): 645–52. https://doi.org/10.1007/s40272-020-00421-3.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Yeo KK, Fukazawa R, Ayusawa M, et al. Asian Pacific Society of Cardiology consensus statement on management of coronary artery disease in adults with late complications of Kawasaki disease. J Asian Pac Soc Cardiol. 2023; 2: e34. https://doi.org/10.15420/japsc.2022.30.</mixed-citation><mixed-citation xml:lang="en">Yeo KK, Fukazawa R, Ayusawa M, et al. Asian Pacific Society of Cardiology consensus statement on management of coronary artery disease in adults with late complications of Kawasaki disease. J Asian Pac Soc Cardiol. 2023; 2: e34. https://doi.org/10.15420/japsc.2022.30.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114(6): 1708–33. https://doi.org/10.1542/peds.2004-2182.</mixed-citation><mixed-citation xml:lang="en">Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics. 2004; 114(6): 1708–33. https://doi.org/10.1542/peds.2004-2182.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Bang JS, Kim GB, Kwon BS, et al. Long-term prognosis for patients with Kawasaki disease complicated by large coronary aneurysm (diameter ≥6 mm). Korean Circ J. 2017; 47(4): 516–22. https://doi.org/10.4070/kcj.2016.0163.</mixed-citation><mixed-citation xml:lang="en">Bang JS, Kim GB, Kwon BS, et al. Long-term prognosis for patients with Kawasaki disease complicated by large coronary aneurysm (diameter ≥6 mm). Korean Circ J. 2017; 47(4): 516–22. https://doi.org/10.4070/kcj.2016.0163.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Matta AG, Yaacoub N, Nader V, et al. Coronary artery aneurysm: a review. World J Cardiol. 2021; 13(9): 446–55. https://doi.org/10.4330/wjc.v13.i9.446.</mixed-citation><mixed-citation xml:lang="en">Matta AG, Yaacoub N, Nader V, et al. Coronary artery aneurysm: a review. World J Cardiol. 2021; 13(9): 446–55. https://doi.org/10.4330/wjc.v13.i9.446.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Агаева З.А., Багдасарян К.А. Методологические аспекты визуализации коронарных артерий при трансторакальной эхокардиографии. Медицинская визуализация. 2018; 22(1): 26–35. https://doi.org/10.24835/1607-0763-2018-1-26-35.</mixed-citation><mixed-citation xml:lang="en">Agaeva ZA, Baghdasaryan KB. Methodological aspects of visualization of coronary arteries with transthoracic echocardiography. Medical Visualization. 2018; 22(1): 26–35 (in Russ). https://doi.org/10.24835/1607-0763-2018-1-26-35.]</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Карпов Р.С., Бощенко А.А., Врублевский А.В. Трансторакальное ультразвуковое исследование магистральных коронарных артерий. Доктор.Ру. 2013; 2: 16–25.</mixed-citation><mixed-citation xml:lang="en">Karpov RS, Boshchenko AA, Vrublevsky AV. Transthoracic ultrasound imaging of main coronary arteries. Doctor.Ru. 2013; 2: 16–25 (in Russ).</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Леонтьева А.А., Ширинская О.Г., Лыскина Г.А., Подчерняева Н.С. Поражение сердца и коронарных артерий при синдроме Кавасаки. Российский вестник перинатологии и педиатрии. 2014; 59(6): 25–31.</mixed-citation><mixed-citation xml:lang="en">Leontyeva AA, Shirinskaya OG, Lyskina GA, Podchernyaeva NS. Heart and coronary artery damage related to Kawasaki syndrome. Russian Bulletin of Perinatology and Pediatrics. 2014; 59(6): 25–31 (in Russ).</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Gellis L, Castellanos DA, Oduor R, et al. Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms. J Cardiovasc Comput Tomogr. 2022; 16(1): 43–50. https://doi.org/10.1016/j.jcct.2021.09.002.</mixed-citation><mixed-citation xml:lang="en">Gellis L, Castellanos DA, Oduor R, et al. Comparison of coronary artery measurements between echocardiograms and cardiac CT in Kawasaki disease patients with aneurysms. J Cardiovasc Comput Tomogr. 2022; 16(1): 43–50. https://doi.org/10.1016/j.jcct.2021.09.002.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Chao BT, Wang XM, Wu LB, et al. Diagnostic value of dual-source CT in Kawasaki disease. Chin Med J (Engl). 2010; 123(6): 670–4.</mixed-citation><mixed-citation xml:lang="en">Chao BT, Wang XM, Wu LB, et al. Diagnostic value of dual-source CT in Kawasaki disease. Chin Med J (Engl). 2010; 123(6): 670–4.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ширинская О.Г., Лыскина Г.А., Бокерия О.Л. и др. Синдром Кавасаки с поражением сердечно-сосудистой системы: отдаленные последствия. Вопросы современной педиатрии. 2013; 12(4): 92–103. https://doi.org/10.15690/vsp.v12i4.735</mixed-citation><mixed-citation xml:lang="en">Shirinskaya OG, Lyskina GA, Bokeriya OL, et al. Kawasaki syndrome with involvement of cardiovascular system: longterm consequences. Current Pediatrics. 2013; 12(4): 92–103 (in Russ). https://doi.org/10.15690/vsp.v12i4.735.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Werner O, Pommier V, Guillaumont S, Vincenti M. Multimodal imaging for cardiac follow-up and management of giant coronary aneurysm related to Kawasaki disease in childhood: a case report. Eur Heart J Case Rep. 2023; 7(10): ytad495. https://doi.org/10.1093/ehjcr/ytad495.</mixed-citation><mixed-citation xml:lang="en">Werner O, Pommier V, Guillaumont S, Vincenti M. Multimodal imaging for cardiac follow-up and management of giant coronary aneurysm related to Kawasaki disease in childhood: a case report. Eur Heart J Case Rep. 2023; 7(10): ytad495. https://doi.org/10.1093/ehjcr/ytad495.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Николаев А.Е., Шапиев А.Н., Блохин И.А. и др. Новые подходы к оценке изменений коронарных артерий при мультиспиральной компьютерной томографии. Российский кардиологический журнал. 2019; 24(12): 124–30. https://doi.org/10.15829/1560-4071-2019-12-124-130.</mixed-citation><mixed-citation xml:lang="en">Nikolaev AE, Shapiev AN, Blokhin IA, et al. New approaches to assessing coronary changes in multi-layer spiral computed tomography. Russian Journal of Cardiology. 2019; 24(12): 124–30 (in Russ). https://doi.org/10.15829/1560-4071-2019-12-124-130.]</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Tsuda E, Hirata T, Matsuo O, et al. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr Cardiol. 2011; 32(2): 176–82. https://doi.org/10.1007/s00246-010-9838-y.</mixed-citation><mixed-citation xml:lang="en">Tsuda E, Hirata T, Matsuo O, et al. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr Cardiol. 2011; 32(2): 176–82. https://doi.org/10.1007/s00246-010-9838-y.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10to 21-year follow-up study of 594 patients. Circulation. 1996; 94(6): 1379–85. https://doi.org/10.1161/01.cir.94.6.1379.</mixed-citation><mixed-citation xml:lang="en">Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10to 21-year follow-up study of 594 patients. Circulation. 1996; 94(6): 1379–85. https://doi.org/10.1161/01.cir.94.6.1379.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Conkbayir C. Правая коронарная артерия, происходящая из левого коронарного синуса: редкая аномалия коронарной артерии. Российский кардиологический журнал. 2014; 1-ENG: 56–7 (на англ. яз.). https://doi.org/10.15829/1560-4071-2014-1-ENG-56-57.</mixed-citation><mixed-citation xml:lang="en">Conkbayir C. Right coronary artery originating from the left coronary sinus: a rare coronary artery anomaly. Russian Journal of Cardiology. 2014; 1-ENG: 56–7. https://doi.org/10.15829/1560-4071-2014-1-ENG-56-57.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Косулина В.М., Башняк В.С., Широбоких О.Е., Крупичка К.С. Аномальное отхождение левой коронарной артерии. RAC-sign. Клинический случай. Кардиоваскулярная терапия и профилактика. 2024; 23(8): 4050. https://doi.org/10.15829/1728-8800-2024-4050.</mixed-citation><mixed-citation xml:lang="en">Kosulina VM, Bashnyak VS, Shirobokikh OE, Krupichka KS. Anomalous origin of left coronary artery. RAC-sign. A case report. Cardiovascular Therapy and Prevention. 2024; 23(8): 4050 (in Russ). https://doi.org/10.15829/1728-8800-2024-4050.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
